Peter David Johnson
University of Oxford
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Peter David Johnson.
Journal of Medicinal Chemistry | 2011
Chancellor; Kay E. Davies; O De Moor; Colin Richard Dorgan; Peter David Johnson; Adam Lambert; D Lawrence; Cristina Lecci; C Maillol; Penny Middleton; Gary Nugent; Severine Danielle Poignant; A Potter; Paul Damien Price; Richard J. Pye; Richard Storer; Jonathon M. Tinsley; R van Well; Richard Vickers; J Vile; Fraser Wilkes; Francis X. Wilson; Stephen Paul Wren; Graham Michael Wynne
A series of novel 2-arylbenzoxazoles that upregulate the production of utrophin in murine H2K cells, as assessed using a luciferase reporter linked assay, have been identified. This compound class appears to hold considerable promise as a potential treatment for Duchenne muscular dystrophy. Following the delineation of structure-activity relationships in the series, a number of potent upregulators were identified, and preliminary ADME evaluation is described. These studies have resulted in the identification of 1, a compound that has been progressed to clinical trials.
Bioorganic & Medicinal Chemistry Letters | 2011
Olivier De Moor; Colin Richard Dorgan; Peter David Johnson; Adam Lambert; Cristina Lecci; Carole Maillol; Gary Nugent; Severine Danielle Poignant; Paul Damien Price; Richard J. Pye; Richard Storer; Jonathon M. Tinsley; Richard Vickers; Renate van Well; Fraser Wilkes; Francis X. Wilson; Stephen Paul Wren; Graham Michael Wynne
Families of 2-arylbenzotriazoles and 2-arylindazoles that show positive effects in screens predictive of endogenous utrophin upregulation have been identified. Synthesis and structure-activity relationships are described leading to compounds with attractive in vitro profiles.
MedChemComm | 2015
John Mann; Peter W. Taylor; Colin Richard Dorgan; Peter David Johnson; Francis X. Wilson; Richard Vickers; Aaron G. Dale; Stephen Neidle
The story of the discovery of the bis-benzimidazole derivative SMT19969, which is currently in clinical trials against the pathogen Clostridium difficile.
Acta Crystallographica Section E-structure Reports Online | 2009
Amber L. Thompson; Agnieszka Michalik; Robert J. Nash; Francis X. Wilson; Renate van Well; Peter David Johnson; George W. J. Fleet; Chu-Yi Yu; Xiang-Guo Hu; Richard I. Cooper; David J. Watkin
X-ray crystallographic analysis of the title hydrobromide salt, C10H20N+·Br−, of (1R,2S,3R,5R,8aR)-3-hydroxymethyl-5-methyloctahydroindolizine-1,2-diol defines the absolute and relative stereochemistry at the five chiral centres in steviamine, a new class of polyhydroxylated indolizidine alkaloid isolated from Stevia rebaudiana (Asteraceae) leaves. In the crystal structure, molecules are linked by intermolecular O—H⋯Br and N—H⋯Br hydrogen bonds, forming double chains around the twofold screw axes along the b-axis direction. Intramolecular O—H⋯O interactions occur.
Chemical Communications | 2001
Timothy J. Donohoe; Peter David Johnson; Madeleine Helliwell; Martine Keenan
The synthesis and aminohydroxylation of a series of acyclic allylic carbamates is described: the formation of a putative O=Os=NR linkage between the transition metal and substrate is proposed to account for the high levels of regioselectivity that were observed; proof of the structure of one of the aminohydroxylation products was obtained through X-ray crystallography.
Management Decision | 2007
Peter David Johnson; Howard Thomas
Purpose – The aim of this paper is to describe “resource margin accounting” (RMA) as a valuation framework in strategic analysis.Design/methodology/approach – The paper defines RMA as an improved framework for valuation in competitive strategy, relative to existing value‐added and cash flow methods. The framework was tested on a sample of 300 US manufacturing companies between 1983 and 1998.Findings – The paper finds that the resource margin approach has greater explanatory power than traditional market‐to‐book valuation measures.Practical implications – The resource margin approach is methodologically and empirically superior to economic value‐added (EVA) and cash flow models of valuation.Originality/value – The paper presents and tests a new valuation method: RMA.
Archive | 2007
Graham Michael Wynne; Stephen Paul Wren; Peter David Johnson; Paul Damien Price; Olivier De Moor; Gary Nugent; Richard Storer; Richard J. Pye; Colin Richard Dorgan
Journal of the American Chemical Society | 2002
Timothy J. Donohoe; Peter David Johnson; and Andrew R. Cowley; Martine Keenan
Archive | 2008
Graham Michael Wynne; Stephen Paul Wren; Peter David Johnson; Paul Damien Price; Olivier De Moor; Gary Nugent; Richard Storer; Richard J. Pye; Colin Richard Dorgan
Organic and Biomolecular Chemistry | 2003
Timothy J. Donohoe; Peter David Johnson; Richard J. Pye